The purpose of this clinical trial was to evaluate the safety and efficacy of a single administration of TRTP-101 in adults with atrophic scars.
Male or Female aged greater than 19 years
Acne scars graded ≥ 3 on the 5-point ASRS
Four or more atrophic scars in the joints, genitals, perineum, and face except for the lips, eyes and nose
Atrophic scar lesions approximately 2 cm in diameter located on the cheeks or temple on both sides of the face
History of cell therapy
Treatment of Dermal resurfacing, Chemical/Mechanical Peel and Skin Photorejuvenation
Treatment of Hyaluronic acid/collagen skin filler, non-permanent soft tissue filler and fat grafting
Positive for virus infection